Stock DNA
Software Products
USD 2,793 Million (Small Cap)
NA (Loss Making)
NA
0.00%
0.29
-13.10%
1.76
Total Returns (Price + Dividend) 
RXO, Inc. for the last several years.
Risk Adjusted Returns v/s 
News

RXO, Inc. Hits Day Low of $12.16 Amid Price Pressure
RXO, Inc., a small-cap software company, saw its stock decline significantly today, reflecting ongoing performance challenges. Despite a high return on capital employed, the company reported a substantial net loss in the first half of the year. Its long-term performance has lagged behind the S&P 500.
Read More
RXO, Inc. Hits 52-Week Low at USD 12.16 Amidst Significant Decline
RXO, Inc., a small-cap software company, has reached a new 52-week low, reflecting a significant decline in its stock performance over the past year. The company has a market capitalization of approximately USD 2,793 million and faces challenges, including negative return on equity and EBITDA, despite high management efficiency.
Read More
RXO, Inc. Hits Day Low of $13.51 Amid Price Pressure
RXO, Inc. has faced notable stock volatility, experiencing a significant decline today and over the past week and month. Despite its high management efficiency and strong debt servicing ability, the company reports negative EBITDA and a substantial drop in net profit, highlighting ongoing financial difficulties.
Read More Announcements 
Corporate Actions 
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2025
Shareholding Compare (%holding) 
Domestic Funds
Held in 75 Schemes (41.73%)
Held by 117 Foreign Institutions (30.27%)
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ
QoQ Growth in quarter ended Jun 2025 is -0.98% vs -14.04% in Mar 2025
QoQ Growth in quarter ended Jun 2025 is 70.97% vs -55.00% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is 15.86% vs -18.12% in Dec 2023
YoY Growth in year ended Dec 2024 is -7,350.00% vs -95.65% in Dec 2023






